Key result
Redesigned nonthoracotomy defibrillator leads achieve ~64% successful implantation, limited by high defibrillation thresholds.
Why the study?
Does a nonthoracotomy defibrillator lead system allow successful implantation in patients requiring an ICD?
Cohort (n=14)
Does a nonthoracotomy defibrillator lead system allow successful implantation in patients requiring an ICD?
Initial clinical experience with a nonthoracotomy ICD lead system demonstrated successful implantation in 9 of 14 patients, though high defibrillation thresholds precluded use in the remainder.
Answers are grounded in this paper and cite their sources.
Initial case series indicates partial success with redesigned leads; leaves open need for larger trials on consistent thresholds.
Standard implantation procedure for the implantable cardioverter defibrillator (ICD) has traditionally required a thoracotomy approach. A newly revised nonthoracotomy defibrillator lead system that uses a single transvenous tripolar endocardial lead alone or in combination with a subcutaneous/submuscular patch lead was introduced into clinical trials in September, 1990. Fourteen patients requiring a cardioverter defibrillator for recurrent sustained ventricular tachycardia (eight patients) or aborted sudden cardiac death (six patients) were evaluated for implantation of this lead system. Primary successful lead system implantation was obtained in nine patients. The remaining five patients had unacceptably high defibrillation thresholds (DFTs) for implantation. One of the nine initially successful implants demonstrated unacceptable DFTs and cross-talk inhibition from a permanent pacemaker necessitating removal of the nonthoracotomy lead system and replacement with a conventional lead system via thoracotomy. All remaining primary implanted patients experienced successful conversion of induced ventricular fibrillation prior to hospital discharge. Continued follow-up and greater experience to confirm the durability and efficacy of the nonthoracotomy AICD lead system are needed.
No takes yet. Share an insight, caveat, or question.
Moore et al. (1991) conducted a cohort in Recurrent sustained ventricular tachycardia or aborted sudden cardiac death (n=14). Nonthoracotomy defibrillator lead system was evaluated on Primary successful lead system implantation. A redesigned nonthoracotomy defibrillator lead system achieved primary successful implantation in 64.3% (9 of 14) of patients, with the remainder having unacceptably high defibrillation thresholds.
Synapse has enriched 10 related papers. Consider them for comparative context: